End Cash: The amount of cash held by the company for the given period.
Aquestive Therapeutics, Inc. (AQST) had End Cash of $95.20M for the most recently reported fiscal quarter, ending 2024-03-31.
Income Statement Financials | |
$12.05M |
|
$-12.83M |
|
$4.39M |
|
$7.66M |
|
$21.01M |
|
$-8.96M |
|
$-3.87M |
|
$-12.83M |
|
$-12.83M |
|
$-12.83M |
|
$-12.83M |
|
$-12.83M |
|
$-12.83M |
|
$-8.96M |
|
$-6.08M |
|
73.61M |
|
73.61M |
|
$-0.17 |
|
$-0.17 |
|
Balance Sheet Financials | |
$113.38M |
|
$4.05M |
|
$16.14M |
|
$129.52M |
|
$18.06M |
|
$28.76M |
|
$147.77M |
|
$165.82M |
|
$-36.30M |
|
$-37.54M |
|
$-36.30M |
|
90.48M |
|
Cash Flow Statement Financials | |
$-10.38M |
|
$-0.03M |
|
$81.74M |
|
$23.87M |
|
End Cash |
$95.20M |
$71.33M |
|
$1.58M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
6.28 |
|
-- |
|
-- |
|
-3.81 |
|
-0.79 |
|
63.59% |
|
-74.31% |
|
-74.31% |
|
-- |
|
-106.43% |
|
-106.43% |
|
$-10.41M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.57 |
|
1.45 |
|
62.16 |
|
35.34% |
|
34.17% |
|
-9.90% |
|
170.09% |
|
$-0.40 |
|
$-0.14 |
|
$-0.14 |